177 related articles for article (PubMed ID: 10741685)
1. Glucose-induced insulin mRNA accumulation is impaired in islets from neonatal streptozotocin-treated rats.
Briaud I; Rouault C; Bailbé D; Portha B; Reach G; Poitout V
Horm Metab Res; 2000 Feb; 32(2):53-6. PubMed ID: 10741685
[TBL] [Abstract][Full Text] [Related]
2. Glucose-induced insulin mRNA accumulation is impaired in islets from neonatal streptozotocin-treated rats.
Briaud I; Rouault C; Bailbé D; Portha B; Reach G; Poitout V
Horm Metab Res; 2000 Mar; 32(3):103-6. PubMed ID: 10786928
[TBL] [Abstract][Full Text] [Related]
3. Differential target molecules for toxicity induced by streptozotocin and alloxan in pancreatic islets of mice in vitro.
Gai W; Schott-Ohly P; Schulte im Walde S; Gleichmann H
Exp Clin Endocrinol Diabetes; 2004 Jan; 112(1):29-37. PubMed ID: 14758569
[TBL] [Abstract][Full Text] [Related]
4. Effect of neonatal streptozotocin and thyrotropin-releasing hormone treatments on insulin secretion in adult rats.
Bacová Z; Najvirtová M; Krizanová O; Hudecová S; Zórad S; Strbák V; Benický J
Gen Physiol Biophys; 2005 Jun; 24(2):181-97. PubMed ID: 16118471
[TBL] [Abstract][Full Text] [Related]
5. S-methyl-L-thiocitrulline counteracts interleukin 1 beta induced suppression of pancreatic islet function in vitro, but does not protect against multiple low-dose streptozotocin-induced diabetes in vivo.
Sternesjö J; Welsh N; Sandler S
Cytokine; 1997 May; 9(5):352-9. PubMed ID: 9195135
[TBL] [Abstract][Full Text] [Related]
6. Effects of timely insulin treatment on protection of beta cells in a rat model of type 2 diabetes mellitus.
Zhou YS; Gao Y; Guo XH; Li B; Wang S; Chi JM
Chin Med J (Engl); 2004 Oct; 117(10):1523-9. PubMed ID: 15498377
[TBL] [Abstract][Full Text] [Related]
7. Beta-cell function and mass in type 2 diabetes.
Larsen MO
Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971
[TBL] [Abstract][Full Text] [Related]
8. Changes in islet microvasculature following streptozotocin-induced beta-cell loss and subsequent replacement in the neonatal rat.
Nicholson JM; Arany EJ; Hill DJ
Exp Biol Med (Maywood); 2010 Feb; 235(2):189-98. PubMed ID: 20404034
[TBL] [Abstract][Full Text] [Related]
9. Metabolic and secretory response to D-fructose in pancreatic islets from adult rats injected with streptozotocin during the neonatal period.
Scruel O; Giroix MH; Sener A; Portha B; Malaisse WJ
Mol Genet Metab; 1999 Sep; 68(1):86-90. PubMed ID: 10479486
[TBL] [Abstract][Full Text] [Related]
10. Galphaolf identification by RT-PCR in purified normal pancreatic B cells and in islets from rat models of non-insulin-dependent diabetes.
Frayon S; Pessah M; Giroix MH; Mercan D; Boissard C; Malaisse WJ; Portha B; Garel JM
Biochem Biophys Res Commun; 1999 Jan; 254(1):269-72. PubMed ID: 9920769
[TBL] [Abstract][Full Text] [Related]
11. Glucose and ATP levels in pancreatic islet tissue of normal and diabetic rats.
Matschinsky FM; Pagliara AS; Stillings SN; Hover BA
J Clin Invest; 1976 Nov; 58(5):1193-200. PubMed ID: 136453
[TBL] [Abstract][Full Text] [Related]
12. Neonatal streptozotocin-induced diabetes mellitus: a model of insulin resistance associated with loss of adipose mass.
Takada J; Machado MA; Peres SB; Brito LC; Borges-Silva CN; Costa CE; Fonseca-Alaniz MH; Andreotti S; Lima FB
Metabolism; 2007 Jul; 56(7):977-84. PubMed ID: 17570261
[TBL] [Abstract][Full Text] [Related]
13. Morphometrical and biochemical differences of endocrine pancreata between spontaneously hypertensive and normotensive rats with or without neonatal streptozotocin-induced diabetes.
Iwase M; Nunoi K; Kikuchi M; Maki Y; Kodama T; Sadoshima S; Fujishima M
Lab Invest; 1989 Jan; 60(1):102-5. PubMed ID: 2521365
[TBL] [Abstract][Full Text] [Related]
14. Influence of postnatal overnutrition and pregnancy on non-insulin dependent diabetes induced in Wistar rats by neonatal streptozotocin.
Mende S; Mühle W; Peters WH
Horm Metab Res; 1996 Feb; 28(2):81-5. PubMed ID: 8867903
[TBL] [Abstract][Full Text] [Related]
15. Effect of cerebrocrast, a new long-acting compound on blood glucose and insulin levels in rats when administered before and after STZ-induced diabetes mellitus.
Briede J; Stivrina M; Stoldere Dz; Vigante B; Duburs G
Cell Biochem Funct; 2007; 25(6):673-80. PubMed ID: 16986170
[TBL] [Abstract][Full Text] [Related]
16. Beta-cell mass depletion precedes the onset of hyperglycaemia in the GK rat, a genetic model of non-insulin-dependent diabetes mellitus.
Movassat J; Saulnier C; Portha B
Diabete Metab; 1995 Dec; 21(5):365-70. PubMed ID: 8586154
[TBL] [Abstract][Full Text] [Related]
17. Studies on sex dependency of B-cell susceptibility to streptozotocin in a rat model of type II diabetes mellitus.
Ostenson CG; Grill V; Roos M
Exp Clin Endocrinol; 1989 May; 93(2-3):241-7. PubMed ID: 2528471
[TBL] [Abstract][Full Text] [Related]
18. Unacylated ghrelin and obestatin increase islet cell mass and prevent diabetes in streptozotocin-treated newborn rats.
Granata R; Volante M; Settanni F; Gauna C; Ghé C; Annunziata M; Deidda B; Gesmundo I; Abribat T; van der Lely AJ; Muccioli G; Ghigo E; Papotti M
J Mol Endocrinol; 2010 Jul; 45(1):9-17. PubMed ID: 20382773
[TBL] [Abstract][Full Text] [Related]
19. The role of clusterin on pancreatic beta cell regeneration after exendin-4 treatment in neonatal streptozotocin administrated rats.
Kaya-Dagistanli F; Ozturk M
Acta Histochem; 2013 Jul; 115(6):577-86. PubMed ID: 23351716
[TBL] [Abstract][Full Text] [Related]
20. Reduction of lns-1 gene expression and tissue insulin levels in n5-STZ rats.
Vargas Guerrero B; García López PM; González Santiago AE; Domínguez Rosales JA; Gurrola Díaz CM
Biol Res; 2013; 46(3):281-8. PubMed ID: 24346076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
